Vytrus Biotech
Vytrus Biotech is a Barcelona-based plant biotechnology company that develops and sells natural active cosmetic ingredients derived from plant stem cells to B2B cosmetic manufacturers and formulation houses across 52+ countries via its proprietary biotech platform portfolio.
- Company typePrivate
- Founded2008
- HeadquartersBarcelona, Spain
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Vytrus Biotech does
Vytrus Biotech is a Barcelona-based plant biotechnology company founded in 2008 as a spin-off from the University of Barcelona's Faculty of Pharmacy. It develops and manufactures high-value natural active ingredients for the cosmetics industry using proprietary plant stem cell biotechnology, operating as a B2B ingredient supplier to cosmetic manufacturers, personal care brands, and formulation companies worldwide.
The company's technology stack is anchored by six proprietary biotechnological platforms: Plant Cell Biofactories, Plasma Rich in Cell Factors (PRCF), Phyto-Peptidic Fractions (PPF), Phyto-Lipidic Fractions (PLF), Phyto-Glucidic Fractions (PGF), and Phyto-Cell Fusions (PCF), with the newer Precision Biofactories™ platform extending into recombinant protein production. Using plant stem cells as biofactories, these platforms produce differentiated bioactive outputs including plant exosomes, peptides, lipid RAFTs, glycoconjugates, and biomimetic proteins. The portfolio comprises 19 commercial active ingredients spanning anti-aging, skin regeneration, microbiome modulation, hair care, neurocosmetic, and sun protection applications. The company holds two US patents covering wound healing applications for Clarivine™ and Centella Reversa™ and has been recognized with multiple industry innovation awards including Best Innovation at in-cosmetics Global 2025.
Vytrus generates revenue by selling ingredients through an international distributor network spanning 52+ countries, with no publicly disclosed price points (B2B quote-based pricing). The company reports €5.9 million in full-year 2025 sales and €6.0 million in H1 2026 (+37% YoY), with a stated 2027 revenue target of €12 million. Capital structure includes a €2.3 million Boyser-led round in May 2024, a €2 million ICF debt facility in January 2026, and listing on BME Growth (Spain's alternative market). A €3.5 million investment in a new Terrassa production plant will triple manufacturing capacity. The company holds EcoVadis Gold (2026) and Platinum (2025) sustainability ratings.
Vytrus Biotech firmographics
Firmographics- Name
- Vytrus Biotech
- Legal name
- VYTRUS BIOTECH S.A.
- Website
- https://vytrus.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Vytrus Biotech is a Barcelona-based plant biotechnology company that develops and sells natural active cosmetic ingredients derived from plant stem cells to B2B cosmetic manufacturers and formulation houses across 52+ countries via its proprietary biotech platform portfolio.
- Ownership category
- akta.pro rank
Where Vytrus Biotech is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
Vytrus Biotech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Active Cosmetic Ingredients B2B Sales: Vytrus Biotech generates revenue by developing and selling natural active ingredients derived from plant stem cells to cosmetic manufacturers, formulation companies, and personal care brands. The company commercializes 16+ cosmetic ingredients through its international distributor network spanning 52+ countries. Revenue comes from ingredient sales to B2B customers in the cosmetics industry.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
Vytrus Biotech product offering
Product offeringCore offering
Vytrus Biotech develops, manufactures, and sells natural active ingredients for the cosmetics industry using proprietary plant stem cell biotechnology. The company produces 19+ branded cosmetic actives (Toleroxyl™, Clarivine™, Capilia Longa™, Centella Reversa™, and others) targeting skin care, hair care, sun care, anti-aging, microbiome modulation, and neurocosmetic applications. Production occurs at industrial scale through seven in-house biotechnological platforms and is commercialized worldwide via an international distributor network covering more than 52 countries.
Product overview
Vytrus Biotech is a Barcelona-based plant biotechnology company that develops and manufactures high-value natural active ingredients for the cosmetics industry on an industrial scale. The company offers a portfolio of 19 distinct cosmetic active ingredients (Toleroxyl™, Ignilyte™, Clarivine™, Baolift™, Photobiome™, Quora Noni™ biomics, Elaya Renova™, Nectaria Lithops™, Deobiome Noni™, Kannabia Sense™, Olea Vitae™, Sarcoslim Re-Shape™, Quora Noni™, Turmeria Zen™, Capilia Longa™, Centella Reversa™, Sensia Carota™, Luminia Granatum™, Arabian Cotton™) based on five proprietary biotechnological platforms: Plant Cell Biofactories, Plasma Rich in Cell Factors (PRCF), Phyto-Peptidic Fractions™ (PPF), Phyto-Lipidic Fractions (PLF), Phyto-Glucidic Fractions (PGF), Phyto-Cell Fusions (PCF), and the newer Precision Biofactories™ platform for recombinant proteins. The products leverage plant stem cell technology to deliver regenerative, anti-aging, microbiome-modulating, and neurocosmetic benefits for skin and hair care applications.
Differentiator
Problem solved
Functional benefit
Brands
- Precision Biofactories™: A platform for identifying the optimal combination of highly active proteins and biological matrices to produce them, combining biotechnology, diverse expression systems, and deep knowledge of biochemistry and biological communication.
Products and services
- Toleroxyl™ Biotech active ingredient designed to treat sensitive and urban skin by re-educating hyperreactive urban skin; the first product of Vytrus's Precision Biofactories™ recombinant protein platform. Sold B2B to cosmetic manufacturers and formulators.
- Ignilyte™ Bioelectric cosmetic active that reactivates skin bioelectrical pathways and mimics device-based electrostimulation naturally; sold B2B to cosmetic formulators.
- Clarivine™ Cosmetic active derived from Vitis vinifera (grapevine) stem cell cultures using exosomic resveratrol, delivering a fasting-mimicking effect on skin for glass skin and longevity applications. Award-winning ingredient covered by US patents for wound healing.
- Baolift™ Skin workout cosmetic active providing a V-lifting effect by training skin for improved firmness and elasticity; sold B2B to cosmetic formulators.
- Photobiome™ Microbial antioxidant cosmetic active that protects skin microbiota from photo-damage and fights microbial-induced photoageing; sold B2B to cosmetic formulators.
- Quora Noni™ biomics Microbiota-focused cosmetic active that rebalances skin microbiota for anti-aging effects including skin firming and perfecting; sold B2B to cosmetic formulators.
- Elaya Renova™ Hair care cosmetic active that boosts scalp anchoring, hydration, regeneration, and protection; provides hair restructuring and reinforcing benefits; sold B2B to cosmetic formulators.
- Nectaria Lithops™ Vitamin D-enriched cosmetic active (cell nectar for D-skin) delivering dewy, deeply hydrated skin; sold B2B to cosmetic formulators.
- Deobiome Noni™ Biological deodorant cosmetic active providing global odor intensity reduction, dandruff reduction, and microbiota rebalancing; sold B2B to personal care formulators.
- Kannabia Sense™ Neurocosmetic active that activates brain pleasure areas and induces better self-perception and positive emotions via the skin-brain connection; sold B2B to cosmetic formulators.
- Olea Vitae™ Anti-aging cosmetic active that revitalizes mature skin by recharging internal cell batteries to tackle energetic ageing; sold B2B to cosmetic formulators.
- Sarcoslim Re-Shape™ Skin remodeling cosmetic active for smart and targeted slimming, acting as a liposculture solution for sculpting curves; sold B2B to cosmetic formulators.
- Quora Noni™ Microbiome communication cosmetic active that reduces sebum production and rebalances skin microbiota; sold B2B to cosmetic formulators.
- Turmeria Zen™ Neurocosmetic active rich in natural plant exosomes with anti-stress wrinkle benefits, modulating brain-skin connection for emotional wellbeing; sold B2B to cosmetic formulators.
- Capilia Longa™ Hair density cosmetic active rich in natural plant exosomes and exopeptides, designed to make hair sprout again; sold B2B to hair care formulators.
- Centella Reversa™
Quantifiable outcome
- 32% sales growth in Q1 2024
- +4 more outcomes
Companies that use Vytrus Biotech
Customer profileSegments2 records
Ideal customer profiles1 record
Vytrus Biotech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Vytrus Biotech partnerships and signals
Strategic signalScale indicators9 records
Recent moves7 records
Expansion highlights5 records
Vytrus Biotech competitors and assessment
Company assessmentDirect peers
- Mibelle Biochemistry: Mibelle Biochemistry is a Swiss manufacturer of cosmetic active ingredients based on plant cell biotechnology and biochemistry. Direct peer due to nearly identical technology platform (plant cells/biotech to produce cosmetic actives) and comparable B2B business model targeting cosmetic formulators.
- Provital Group: Provital Group is a Barcelona-based manufacturer of natural active ingredients for cosmetics and personal care, also founded by a team with academic roots. Direct peer sharing geographic home market, B2B model, and botanical active ingredient portfolio, competing for similar formulation customers.
- CLR Berlin: CLR Berlin is a German manufacturer of natural and biotechnology-based active ingredients for the cosmetics industry. Direct peer operating in plant cell cultures and biotech actives at comparable scale to Vytrus, serving the same B2B cosmetic formulator customer base.
- Sederma (Croda): Sederma is a French specialist in bioactive cosmetic ingredients including peptides and plant-derived actives, owned by Croda International. Direct peer in peptide/biomimetic cosmetic actives, though now operating with significantly larger parent resources for global distribution.
- Lucas Meyer Cosmetics (IFF): Lucas Meyer Cosmetics develops phospholipids, peptides, and biotech-derived cosmetic actives, now part of IFF. Direct peer in specialty cosmetic actives with similar technology-forward approach, though benefiting from IFF's global scale.
Broad incumbents
- Givaudan Active Beauty: Givaudan Active Beauty is the cosmetic ingredients division of Swiss fragrance giant Givaudan, offering a broad portfolio including biotech actives. Broad incumbent that competes with Vytrus for premium cosmetic brand accounts but operates at much greater scale with diverse technology platforms.
- DSM-Firmenich: DSM-Firmenich is a global specialty ingredients company with personal care actives spanning vitamins, peptides, and biotech-derived ingredients. Broad incumbent with overlapping cosmetic active ingredient portfolio but vastly larger resources and broader end-market exposure including nutrition and pharma.
- Symrise Diana Food: Symrise is a major German flavors and fragrances company with a Diana division that develops natural and biotech-based cosmetic ingredients. Broad incumbent serving similar cosmetic formulator customers but with broader portfolio and significantly larger global footprint.
- Evonik Care Solutions: Evonik's Personal Care & Cosmetics business develops specialty ingredients including biotechnology-derived actives for skincare. Broad incumbent with overlapping biotech active ingredients offering but operating within a much larger specialty chemicals portfolio across multiple industries.
- BASF Care Creations: BASF's Care Creations division supplies cosmetic ingredients including plant-based and biotechnology-derived actives. Broad incumbent competing in the same ingredient supply value chain but with portfolio spanning thousands of ingredients across multiple industries and global scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key highlights7 records
Customer concentration
Vytrus Biotech social profiles
Digital presenceVytrus Biotech compliance and trust
Trust signalCompliance3 records
Vytrus Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vytrus Biotech leadership team
Management profileNumber of profiles
Profiles1 record
Vytrus Biotech funding detail
Funding detailFunding overview
Funding rounds6 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vytrus Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vytrus Biotech
What does Vytrus Biotech do?
Vytrus Biotech develops, manufactures, and sells natural active ingredients for the cosmetics industry using proprietary plant stem cell biotechnology. The company produces 19+ branded cosmetic actives (Toleroxyl™, Clarivine™, Capilia Longa™, Centella Reversa™, and others) targeting skin care, hair care, sun care, anti-aging, microbiome modulation, and neurocosmetic applications. Production occurs at industrial scale through seven in-house biotechnological platforms and is commercialized worldwide via an international distributor network covering more than 52 countries.
Is Vytrus Biotech a public or private company?
Vytrus Biotech is a private company. It is classified as venture growth investor backed and is currently operating.
When was Vytrus Biotech founded?
Vytrus Biotech was founded in 2008. It employs 11 to 50 people.
Where is Vytrus Biotech based?
Vytrus Biotech is headquartered in Barcelona, Spain, in the Europe region.
How does Vytrus Biotech make money?
One revenue line is on record: active Cosmetic Ingredients B2B Sales.
Who are Vytrus Biotech's main competitors?
Direct peers on record are Mibelle Biochemistry, Provital Group, CLR Berlin, Sederma (Croda) and Lucas Meyer Cosmetics (IFF). Broad incumbents are Givaudan Active Beauty, DSM-Firmenich, Symrise Diana Food, Evonik Care Solutions and BASF Care Creations.
Does Vytrus Biotech have an API?
No public API is recorded for Vytrus Biotech.